Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003–2012

Fig. 1

Oral and cervicogenital HPV prevalence and type-concordance for women ages 14–59. Oral (a and b) and genital (c and d) prevalence are given by age and race in 2009–10 and 2011–12 and are separated into type-concordant and non-type-concordant infections. Type-concordant infections represent a simultaneous oral and cervicogenital infection of the same genotype

Back to article page